Novartis to acquire kidney disease drug maker Regulus Therapeutics for up to 1.7 billion Ruchika Sharma1 May 2025 12:30 PM ISTTransaction includes USD 0.8 billion upfront with a potential additional USD 0.9 billion payment upon the achievement of a future regulatory...
Lupin gets green light from USFDA for kidney drug Tolvaptan Ruchika Sharma24 April 2025 11:52 AM ISTMumbai: Global pharma major, Lupin Limited, has received approval from the United States Food and Drug Administration (U.S. FDA) for...
A new drug candidate can shrink kidney cysts Dr. Kamal Kant Kohli13 Feb 2024 7:00 AM ISTAutosomal dominant polycystic kidney disease (ADPKD), the most common form of polycystic kidney disease, can lead to kidney enlargement and eventual...
Tolvaptan delays disease progression in polycystic kidney disease patients Dr. Mahalakshmi Sivashankaran17 May 2023 8:30 PM ISTChina: A recent meta-analysis published in Nefrologia journal has suggested that Tolvaptan, a medication used to delay the progression of autosomal...
Tolvaptan use tied to changes in mineral metabolism parameters and increased BMD in polycystic kidney disease Medha Baranwal18 Nov 2022 8:00 PM ISTSwitzerland: Chronic treatment with Tolvaptan is tied to an increased femoral bone mineral density (BMD), and remarkable changes in both acid-base...
Massive kidneys weighing 7 Kgs and 5.8 Kgs removed from a 41-year-old at Global Hospital Medical Dialogues Bureau27 Feb 2020 12:30 PM ISTThe patient was suffering from autosomal dominant polycystic kidney disease (ADPKD)
